Inventor · disambiguated record
Wei He
Also filed as: HE WEI · HE WEI W · HE WEI WU
121 granted patents·63 pending applications·2,098 citations·filing 1993–2025
99Inventor score
Files withHUMAN GENOME SCIENCES INC30ACCUTAR BIOTECHNOLOGY INC24JANSSEN PHARMACEUTICA NV15COATS STEVEN J7ZHEJIANG DTRM BIOPHARMA CO LTD7
Top patents by PatentIndex Score
184 records- 0199US6528526B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2000·Granted Mar 4, 2003·305 cites·37 claims
- 0299US6180632B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARM PROD INC·Filed 1998·Granted Jan 30, 2001·395 cites·79 claims
- 0398US6482834B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2001·Granted Nov 19, 2002·254 cites·50 claims
- 0498US6245760B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARM PROD INC·Filed 1998·Granted Jun 12, 2001·257 cites·57 claims
- 0597US11420956B2Ureas having Androgen Receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Aug 23, 2022·6 cites·21 claims
- 0697US10800770B1Chroman derivatives having estrogen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Oct 13, 2020·9 cites·22 claims
- 0797US9717745B2Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseasesZHEJIANG DTRM BIOPHARMA CO LTD·Filed 2016·Granted Aug 1, 2017·18 cites·16 claims
- 0896US11312702B2Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Apr 26, 2022·4 cites·20 claims
- 0996US9700542B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jul 11, 2017·18 cites·19 claims
- 1096US7741356B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jun 22, 2010·38 cites·43 claims
- 1195US11713359B2Apolipoprotein nanodiscs with telodendrimerL LIVERMORE NAT SECURITY LLC·Filed 2021·Granted Aug 1, 2023·3 cites·19 claims
- 1295US11535606B2Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Dec 27, 2022·4 cites·34 claims
- 1395US11261178B2Chroman derivatives having estrogen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Mar 1, 2022·5 cites·9 claims
- 1495US10836749B1Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Nov 17, 2020·3 cites·25 claims
- 1595US7786158B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 31, 2010·23 cites·29 claims
- 1694US11053322B2Apolipoprotein nanodiscs with telodendrimerL LIVERMORE NAT SECURITY LLC·Filed 2017·Granted Jul 6, 2021·8 cites·19 claims
- 1794US9644038B2Apolipoprotein nanodiscs with telodendrimerUNIV CALIFORNIA·Filed 2012·Granted May 9, 2017·18 cites·20 claims
- 1893US11220490B2Ureas having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2021·Granted Jan 11, 2022·2 cites·10 claims
- 1993US8772325B2Compounds as opioid receptor modulatorsJANNSEN PHARMACEUTICA N V·Filed 2013·Granted Jul 8, 2014·15 cites·23 claims
- 2093US8344011B2Compounds as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 1, 2013·17 cites·78 claims
- 2192US9205076B2Compounds as opioid receptor modulatorsJANNSEN PHARMACEUTICA N V·Filed 2014·Granted Dec 8, 2015·12 cites·24 claims
- 2292US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
- 2392US8609709B2Compounds as opioid receptor modulatorsJANNSEN PHARMACEUTICA N V·Filed 2012·Granted Dec 17, 2013·11 cites·8 claims
- 2491US8440658B2Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted May 14, 2013·16 cites·19 claims
- 2591US7282351B2Prostatic growth factorHUMAN GENOME SCIENCES INC·Filed 2002·Granted Oct 16, 2007·28 cites·17 claims
- 2690US9532990B2Polyfluorinated compounds acting as bruton tyrosine kinase inhibitorsHE WEI·Filed 2016·Granted Jan 3, 2017·8 cites·28 claims
- 2790US7741055B2Prostatic growth factorHUMAN GENOME SCIENCES INC·Filed 2007·Granted Jun 22, 2010·5 cites·14 claims
- 2890US6733981B2Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4HUMAN GENOME SCIENCES INC·Filed 2001·Granted May 11, 2004·25 cites·31 claims
- 2990US5538892ANucleic acids encoding a TGF-β type 1 receptorGEN HOSPITAL CORP·Filed 1993·Granted Jul 23, 1996·83 cites·21 claims
- 3087US10537587B2Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseasesZHEJIANG DTRM BIOPHARMA CO LTD·Filed 2018·Granted Jan 21, 2020·2 cites·17 claims
- 3187US9861636B2Polyfluorinated compounds acting as bruton tyrosine kinase inhibitorsHE WEI·Filed 2016·Granted Jan 9, 2018·5 cites·30 claims
- 3287US7629488B2Process for the preparation of opioid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Dec 8, 2009·8 cites·10 claims
- 3386US12371512B2Apolipoprotein nanodiscs with telodendrimerL LIVERMORE NAT SECURITY LLC·Filed 2023·Granted Jul 29, 2025·0 cites·19 claims
- 3484US6696434B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2002·Granted Feb 24, 2004·14 cites·62 claims
- 3584US6656743B2Human choline acetyltransferaseHUMAN GENOME SCIENCES INC·Filed 2002·Granted Dec 2, 2003·7 cites·32 claims
- 3684US6316193B1Rapid-screen cDNA library panelsORIGENE TECHNOLOGIES INC·Filed 1999·Granted Nov 13, 2001·57 cites·22 claims
- 3783US10596183B2Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseasesZHEJIANG DTRM BIOPHARMA CO LTD·Filed 2018·Granted Mar 24, 2020·2 cites·3 claims
- 3883US8575156B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted Nov 5, 2013·5 cites·20 claims
- 3983US7902358B2Prokineticin 1 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Mar 8, 2011·7 cites·29 claims
- 4082US8846655B24-substituted-2-phenoxy-phenylamine delta opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Sep 30, 2014·7 cites·24 claims
- 4182US7968710B2Prokineticin 1 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 28, 2011·6 cites·48 claims
- 4282US6521227B1Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptidesFiled 1999·Granted Feb 18, 2003·56 cites·28 claims
- 4381US5547854ADNA encoding a receptor for Mullerian inhibitory substance, misr1, and corresponding vectors, cells, probes, and recombinant methodsGEN HOSPITAL CORP·Filed 1994·Granted Aug 20, 1996·42 cites·27 claims
- 4480US10696659B2Compounds having estrogen receptor alpha degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2019·Granted Jun 30, 2020·2 cites·30 claims
- 4580US10300066B2Polyfluorinated compounds acting as bruton tyrosine kinase inhibitorsZHEJIANG DTRM BIOPHARMA CO LTD·Filed 2017·Granted May 28, 2019·2 cites·19 claims
- 4680US6500638B2Prostatic growth factorHUMAN GENOME SCIENCES INC·Filed 1999·Granted Dec 31, 2002·36 cites·55 claims
- 4780US2025361153A1Positive electrode material, and preparation method therefor and use thereofEVE POWER CO LTD·Filed 2025·Application pending·0 cites
- 4879US12195459B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Granted Jan 14, 2025·0 cites·46 claims
- 4979US12110291B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·32 claims
- 5079US6010878AInterleukin-1 β converting enzyme like apoptotic protease-6SMITHKLINE BEECHAM CORP·Filed 1997·Granted Jan 4, 2000·33 cites·15 claims
Showing the top 50 of 184 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wei He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →